Jeremy M Silverman Selected Research

Jeremy M Silverman Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2009
12	Schizophrenia (Dementia Praecox) 01/2023 - 04/2002
10	Dementia (Dementias) 01/2021 - 04/2005
9	Autistic Disorder (Autism) 12/2014 - 04/2004
8	Cognitive Dysfunction 01/2021 - 01/2009
5	Inflammation (Inflammations) 10/2015 - 05/2007
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2009
3	Autism Spectrum Disorder 12/2014 - 04/2008
3	Hypertension (High Blood Pressure) 01/2012 - 05/2007
2	Diabetes Complications 01/2020 - 01/2019
2	Intellectual Disability (Idiocy) 03/2011 - 06/2007
2	Personality Disorders (Personality Disorder) 01/2006 - 10/2003
1	Neurodevelopmental Disorders 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 04/2015
1	Chronic Renal Insufficiency 11/2009
1	Infections 08/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2009
1	Megalencephaly 06/2007
1	Polydactyly (Polydactylism) 06/2007
1	Language Development Disorders (Semantic-Pragmatic Disorder) 06/2007
1	Hypercholesterolemia 05/2007
1	Atrial Fibrillation 05/2007
1	Hyperhomocysteinemia 05/2007
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2006
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2006
1	Amyloid Plaque 04/2005
1	Schizotypal Personality Disorder 05/2003

Drug/Important Bio-Agent (IBA)

4	HaptoglobinsIBA 01/2020 - 10/2013
4	Apolipoprotein E4IBA 08/2014 - 04/2005
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2014
3	Hemoglobins (Hemoglobin)IBA 01/2019 - 10/2014
3	CholesterolIBA 01/2018 - 05/2007
3	Serotonin (5 Hydroxytryptamine)IBA 12/2014 - 12/2006
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2023 - 01/2021
2	C-Reactive ProteinIBA 10/2015 - 09/2012
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2015 - 05/2003
2	Antipsychotic Agents (Antipsychotics)IBA 04/2015 - 02/2014
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2014 - 07/2006
2	Oxidants (Oxidizing Agents)IBA 11/2011 - 11/2009
2	EnzymesIBA 12/2010 - 12/2006
2	AntioxidantsIBA 11/2009 - 05/2007
2	aspartate-glutamate carrierIBA 04/2008 - 04/2004
1	Sp4 Transcription FactorIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Vitamin E FDA LinkGeneric 01/2020
1	Caffeine (No Doz)FDA LinkGeneric 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2015
1	ApolipoproteinsIBA 10/2014
1	Poly TIBA 09/2014
1	Metalloproteases (Metalloproteinases)IBA 03/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	Pyruvaldehyde (Methylglyoxal)IBA 11/2011
1	Glutamic Acid (Glutamate)FDA Link 09/2011
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 03/2011
1	A-factor (Streptomyces)IBA 01/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2010
1	Dietary Advanced Glycation End ProductsIBA 11/2009
1	Advanced Glycation End ProductsIBA 11/2009
1	Histones (Histone)IBA 08/2009
1	ChromatinIBA 08/2009
1	UbiquitinIBA 05/2009
1	Apolipoproteins E (ApoE)IBA 01/2009
1	ORALIT (ORS)IBA 11/2008
1	Amino Acids FDA Link 06/2007
1	Hemostatics (Antihemorrhagics)IBA 05/2007
1	Free RadicalsIBA 05/2007
1	FatsIBA 05/2007
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2006
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 07/2006
1	Hormones (Hormone)IBA 01/2006
1	5-HT1A Serotonin ReceptorIBA 01/2006
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2006
1	ProlactinIBA 01/2006
1	ipsapironeIBA 01/2006
1	AminesIBA 10/2004
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2003
1	Genetic Markers (Genetic Marker)IBA 04/2002

Therapy/Procedure

5	Glycemic Control 01/2019 - 01/2014
1	Cognitive Training 01/2019
1	Ligation 10/2008
1	Oral Administration 01/2006
1	Home Nursing (Nursing, Home) 05/2005